Eledon Pharmaceuticals, Inc. (ELDN) Tops Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts ELDN Hot Sheet
Join SI Premium – FREE
Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) reported Q1 EPS of ($0.08), $0.17 better than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Eledon Pharmaceuticals, Inc. (ELDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- loanDepot receives NYSE non-compliance notice over stock price
- Real and RE/MAX Holdings receive court approval for merger
- Solowin Holdings marks 10 years, expands into stablecoins and AI
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
